It has been discovered that weekly injections of a myostatin-neutralizing antibody for four weeks dramatically raise the weights of particular muscles by up to 17% [73,74]. Several myostatin inhibitors are now in clinical research for several reasons, primarily cachexia, early postoperative recovery, and sarcopenia. Here, MSTN is linked to sarcopenia.